respiratory disease therapy (Ligand/GSK)

N/A

Report date: 2025/03/20 09:39:43
NME

Base Information

Drug Namerespiratory disease therapy (Ligand/GSK)
Drug Alias Namerespiratory disease therapy (Pharmacopeia/GSK)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacopeia Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacopeia LlcLigand Pharmaceuticals IncGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A